Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%

    1 day ago

    The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.
    Click here to Read More
    Previous Article
    From Indian Enterprise to Global Ambition: Dr. Sachidanand Upadhyay Marks Third Consecutive Year in TIME Magazine
    Next Article
    Cabinet Opens Path For All Agniveers to Join Armed Forces After 2-Year Extension

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment